HomeGeneticsConditionsIsolated sulfite oxidase deficiency
Back to Conditions
Isolated sulfite oxidase deficiency
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Conditions

Isolated sulfite oxidase deficiency

Isolated sulfite oxidase deficiency is a rare, severe neurological disorder that impairs brain development, causing seizures, muscle stiffness, and developmental regression. It exists in both a classic neonatal form and a milder, late-onset form.

Description

Isolated sulfite oxidase deficiency (ISOD) is a disorder of the nervous system, with a severe "classic" form that starts in the newborn period and a milder, late-onset form that begins later in infancy or early childhood.

Classic ISOD

Classic ISOD appears within the first few days after birth with signs and symptoms of brain dysfunction (encephalopathy) that quickly get worse. Babies with classic ISOD have seizures that are difficult to treat and feeding difficulties. They have muscle stiffness that results in paralysis of the arms and legs (spastic quadriplegia) and episodes of muscle spasms that cause backward arching of the spine (opisthotonus). Because development of the brain is impaired, the head does not grow at the same rate as the body, so it appears that the head is getting smaller as the body grows (progressive microcephaly).

Abnormalities in facial features also become increasingly pronounced with lack of normal head growth. These facial differences include a relatively long and narrow face; deep-set, widely-spaced eyes; elongated openings of the eyes (palpebral fissures); puffy cheeks; a small nose; a large space between the nose and upper lip; and thick lips.

Babies with classic ISOD do not respond to their environment except to startle easily in response to noises, and they do not develop any motor skills such as turning over or sitting up. They usually do not live for more than a few months. Affected individuals who survive past infancy usually develop displacement of the lenses of the eyes (ectopia lentis). Because these individuals do not react to visual stimuli (are behaviorally blind) due to the brain damage associated with classic ISOD, the ectopia lentis has no further impact on their vision.

Late-Onset ISOD

Late-onset ISOD usually begins between the ages of 6 and 18 months, often after an illness involving fever. Individuals with this form of the disorder may not have the seizures and ectopia lentis that usually occur in the classic form. They have developmental delay and may lose skills that they had already developed (developmental regression). Movement problems occur in this form of the disorder, including muscle tensing (dystonia), uncontrolled movements of the limbs (choreoathetosis), and difficulty with coordination (ataxia). The signs and symptoms of late-onset ISOD can gradually get worse (progress), or they can be episodic, which means that they come and go. Some individuals with this form of ISOD survive into childhood or adolescence; because of the rarity of this disorder, their life expectancy is unknown.

Frequency

The prevalence of ISOD is unknown. At least 50 affected individuals have been described in the medical literature.

Causes

ISOD is caused by mutations in the SUOX gene. This gene provides instructions for making an enzyme called sulfite oxidase, which helps break down protein building blocks (amino acids) that contain sulfur when they are no longer needed. Specifically, sulfite oxidase is involved in the final step of this process, in which sulfur-containing molecules called sulfites are converted to other molecules called sulfates by adding an oxygen atom (a process called oxidation).

The SUOX gene mutations that cause ISOD impair the function of sulfite oxidase, preventing complete breakdown of sulfur-containing amino acids. As a result, sulfites and other compounds left over from the partial breakdown process abnormally accumulate in the body. Researchers suggest that the nervous system is especially sensitive to this abnormal accumulation, and excessive levels of sulfite compounds that are toxic to the brain are thought to result in the brain damage that occurs in ISOD. It is unclear why most affected individuals have the classic form of the condition while a smaller number develop the milder late-onset form.

Associated Gene

  • SUOX

Inheritance

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Other Names for This Condition

  • Encephalopathy due to sulfite oxidase deficiency
  • ISOD
  • Sulfocysteinuria

Frequently Asked Questions

Diagnosis relies on a combination of clinical suspicion, plasma and urine biochemical testing (elevated sulfite, thiosulfate, and S‑sulfocysteine levels), and confirmation by molecular genetic testing of the SUOX gene. Newborn screening programs in some regions include a sulfite test, but a targeted metabolic work‑up is often needed when symptoms appear.
Classic ISOD is inherited in an autosomal‑recessive manner; both parents are carriers of one pathogenic SUOX variant. Each subsequent pregnancy carries a 25 % chance of an affected child, a 50 % chance of a carrier, and a 25 % chance of an unaffected, non‑carrier child. Genetic counseling and carrier testing for extended family members are advised.
low‑protein diet that restricts methionine and cysteine (the sulfur‑containing amino acids) can reduce substrate load for sulfite production. This must be supervised by a metabolic specialist to ensure adequate growth and prevent essential amino‑acid deficiency. Supplementation with antioxidants such as vitamin C and molybdenum may be considered, although evidence is limited.
Early initiation of physiotherapy to maintain joint range of motion, speech therapy for communication delays, and seizure control with antiepileptic drugs are key. Regular ophthalmologic and audiologic monitoring is recommended because visual and hearing deficits can develop. Nutritional support via gastrostomy may be needed if oral intake is insufficient.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA

About UsTerms & PolicyFAQ